Tearsheet

Ensign (ENSG)


Market Price (12/18/2025): $176.605 | Market Cap: $10.1 Bil
Sector: Health Care | Industry: Health Care Facilities

Ensign (ENSG)


Market Price (12/18/2025): $176.605
Market Cap: $10.1 Bil
Sector: Health Care
Industry: Health Care Facilities

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Low stock price volatility
Vol 12M is 26%
Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 30x
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.
Key risks
ENSG key risks include [1] its heavy reliance on government reimbursement, Show more.
0 Low stock price volatility
Vol 12M is 26%
1 Megatrend and thematic drivers
Megatrends include Aging Population & Chronic Disease. Themes include Geriatric Care.
2 Expensive valuation multiples
P/EPrice/Earnings or Price/(Net Income) is 30x
3 Key risks
ENSG key risks include [1] its heavy reliance on government reimbursement, Show more.

Valuation, Metrics & Events

ENSG Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

The Ensign Group (ENSG) stock experienced a 2.8% movement between approximately August 31, 2025, and December 18, 2025, driven by several key factors:

1. Strong Third Quarter 2025 Earnings Beat. The Ensign Group reported its third-quarter 2025 financial results on November 3, 2025, surpassing analyst expectations for both adjusted earnings per share (EPS) and revenue. The company announced an adjusted EPS of $1.64, exceeding the forecast of $1.61, and revenue of $1.3 billion, which was above the anticipated $1.28 billion.

2. Raised Annual Earnings and Revenue Guidance. Following the strong Q3 performance, Ensign Group raised its annual 2025 earnings guidance to between $6.48 and $6.54 per diluted share, an increase from the previous guidance of $6.34 to $6.46. The company also increased its annual revenue guidance to between $5.05 billion and $5.07 billion.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
ENSG Return61%15%13%19%19%32%292%
Peers Return92%4%-47%16%5%69%114%
S&P 500 Return16%27%-19%24%23%14%108%

Monthly Win Rates [3]
ENSG Win Rate50%50%58%67%58%67% 
Peers Win Rate68%50%33%58%45%50% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
ENSG Max Drawdown-45%-5%-15%-8%0%-10% 
Peers Max Drawdown-35%-21%-67%-17%-43%-9% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: NTRA, GH, OPCH, PGNY, TDOC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)

How Low Can It Go

Unique KeyEventENSGS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-28.0%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven38.8%34.1%
2022 Inflation ShockTime to BreakevenTime to Breakeven420 days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-53.1%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven113.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven143 days148 days
2018 Correction2018 Correction  
2018 Correction% Loss% Loss-35.3%-19.8%
2018 Correction% Gain to Breakeven% Gain to Breakeven54.6%24.7%
2018 CorrectionTime to BreakevenTime to Breakeven391 days120 days
2008 Global Financial Crisis2008 Global Financial Crisis  
2008 Global Financial Crisis% Loss% Loss-54.8%-56.8%
2008 Global Financial Crisis% Gain to Breakeven% Gain to Breakeven121.4%131.3%
2008 Global Financial CrisisTime to BreakevenTime to Breakeven160 days1,480 days

Compare to NTRA, GH, OPCH, PGNY, TDOC


In The Past

Ensign's stock fell -28.0% during the 2022 Inflation Shock from a high on 3/26/2021. A -28.0% loss requires a 38.8% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Ensign (ENSG)

Better Bets than Ensign (ENSG)

Trade Ideas

Select past ideas related to ENSG. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.3%16.3%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.1%-7.1%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.6%3.6%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
1.6%1.6%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.1%14.1%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.3%16.3%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-7.1%-7.1%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.6%3.6%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
1.6%1.6%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.1%14.1%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Ensign

Peers to compare with:

Financials

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
Mkt Price176.57225.4997.4732.9725.997.2565.22
Mkt Cap10.130.912.25.32.21.37.7
Rev LTM4,8292,1179035,5301,2692,5282,322
Op Inc LTM402-352-44233386-179-46
FCF LTM4994-262221193140117
FCF 3Y Avg132-87-300279184153142
CFO LTM481194-223259208293233
CFO 3Y Avg385-17-271320192305249

Growth & Margins

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
Rev Chg LTM17.5%38.2%30.4%15.8%11.4%-2.4%16.7%
Rev Chg 3Y Avg18.4%40.2%28.0%12.9%23.1%3.0%20.8%
Rev Chg Q19.8%34.7%38.5%12.2%9.3%-2.2%16.0%
QoQ Delta Rev Chg LTM4.7%7.8%8.9%2.9%2.2%-0.6%3.8%
Op Mgn LTM8.3%-16.6%-49.0%6.0%6.8%-7.1%-0.5%
Op Mgn 3Y Avg7.9%-27.8%-73.1%6.6%5.8%-7.6%-0.9%
QoQ Delta Op Mgn LTM-0.2%-1.7%6.6%-0.2%0.6%0.2%-0.0%
CFO/Rev LTM10.0%9.2%-24.7%4.7%16.4%11.6%9.6%
CFO/Rev 3Y Avg9.2%-5.5%-41.4%6.8%16.8%11.9%8.0%
FCF/Rev LTM1.0%4.4%-29.1%4.0%15.2%5.5%4.2%
FCF/Rev 3Y Avg3.4%-10.0%-45.5%5.9%16.2%6.0%4.7%

Valuation

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
Mkt Cap10.130.912.25.32.21.37.7
P/S2.110.48.60.81.50.51.8
P/EBIT22.6-72.3-19.813.421.6-6.03.7
P/E30.2-71.4-19.621.532.7-6.17.7
P/CFO20.6113.7-35.017.48.94.713.1
Total Yield3.5%-1.4%-5.1%4.7%3.1%-16.3%0.8%
Dividend Yield0.1%0.0%0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg2.1%-2.0%-7.8%5.3%9.1%9.0%3.7%
D/E0.20.00.20.30.00.80.2
Net D/E0.2-0.00.10.2-0.20.20.1

Returns

ENSGNTRAGHOPCHPGNYTDOCMedian
NameEnsign Natera Guardant.Option C.Progyny Teladoc . 
1M Rtn-0.6%9.4%1.0%17.3%-3.1%7.4%4.2%
3M Rtn6.4%28.5%70.4%17.6%20.2%-8.2%18.9%
6M Rtn13.0%31.9%92.7%4.5%20.0%3.4%16.5%
12M Rtn26.3%34.1%179.8%40.8%76.3%-28.0%37.4%
3Y Rtn85.7%420.5%224.3%10.6%-18.3%-73.2%48.2%
1M Excs Rtn-1.3%8.7%0.3%16.6%-3.8%6.7%3.5%
3M Excs Rtn4.4%24.0%64.4%14.7%14.1%-13.6%14.4%
6M Excs Rtn0.6%19.5%80.4%-7.9%7.7%-9.0%4.1%
12M Excs Rtn13.1%24.3%169.3%29.3%66.8%-41.5%26.8%
3Y Excs Rtn22.7%406.5%43.6%-59.7%-85.2%-142.5%-18.5%

Financials

Segment Financials

Revenue by Segment

$ Mil20242023202220212020
Skilled Services3,5792,9062,5232,2881,934
All other revenue1561231039997
Standard Bearer827358  
Elimination of intercompany revenue-88-76-57-46-45
Real Estate   6150
Total3,7293,0252,6272,4032,037


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity1,621,548
Short Interest: % Change Since 111520256.4%
Average Daily Volume337,477
Days-to-Cover Short Interest4.80
Basic Shares Quantity57,382,000
Short % of Basic Shares2.8%

Returns Analyses

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
11/3/20250.1%-1.3%-3.2%
7/24/20258.9%8.9%25.2%
4/29/20250.7%4.2%14.4%
2/5/2025-8.7%-15.3%-12.4%
10/24/20242.7%4.1%-1.7%
7/25/20244.9%2.5%8.7%
5/1/2024-2.4%-2.8%1.5%
2/1/20244.7%2.3%9.2%
...
SUMMARY STATS   
# Positive141515
# Negative1099
Median Positive4.8%4.9%12.3%
Median Negative-2.5%-3.5%-7.7%
Max Positive15.0%15.7%26.4%
Max Negative-8.7%-15.3%-28.8%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251103202510-Q 9/30/2025
6302025724202510-Q 6/30/2025
3312025429202510-Q 3/31/2025
12312024205202510-K 12/31/2024
93020241024202410-Q 9/30/2024
6302024725202410-Q 6/30/2024
3312024501202410-Q 3/31/2024
12312023201202410-K 12/31/2023
93020231025202310-Q 9/30/2023
6302023727202310-Q 6/30/2023
3312023426202310-Q 3/31/2023
12312022202202310-K 12/31/2022
93020221026202210-Q 9/30/2022
6302022801202210-Q 6/30/2022
3312022428202210-Q 3/31/2022
12312021209202210-K 12/31/2021